Ekarpen, a private equity firm backed by the government of the Basque Country, and Basque lender BBK have led a €9m funding round for Spanish biotechnology company Oncomatryx.
VCs Serena and Isai re-up, having previously backed the €5m series-A in 2016
Third investment made by Alto Capital IV, which held a €210m final close in 2018
Based in London and Frankfurt, Wunderlin will report to group chief executive Peter Harrison
Ardian bought a majority stake in France-based Revima from Argos Wityu last month